B. Riley Financial, Inc. (Nasdaq: RILY) (the “Company”) today announced that the Company will change its name to BRC Group Holdings, Inc. (“BRC”), effective on January 1, 2026. BRC Group Holdings will continue to be a diverse portfolio of companies, including financial services, telecom, and retail, and investments in equity, debt and venture capital. Bryant […]

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that members of the management team will participate at the following investor conferences: https://mma.prnewswire.com/media/678850/Neurocrine_Biosciences_Logo.jpg — Jefferies Global Healthcare Conference. Fireside chat on Tuesday, November 18, 2025 at 12:00 PM GMT (7:00 AM ET) in London — Piper Sandler 37th Annual Healthcare Conference. Fireside chat on Tuesday, December 2,

(NASDAQ:MGX), MGX-001 demonstrated curative FVIII activity in non-human primates Pre-IND regulatory meeting expected in Q4 2025 with investigational new drug (IND) and clinical trial application (CTA) submissions expected in 4Q 2026 EMERYVILLE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary

(NASDAQ:ASTE), CHATTANOOGA, Tenn., Nov. 11, 2025 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ:ASTE) announced today it will participate in the Stephens Investment Conference (NASH2025) on Tuesday, November 18, 2025, in Nashville, Tennessee. Jaco van der Merwe, President and Chief Executive Officer, Brian Harris, Chief Financial Officer, and Stephen C. Anderson, Senior Vice President of Administration

(NYSE MKT:STXS), ST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2025. “We continue to focus on driving commercial progress while advancing a robust portfolio of technologies through regulatory

Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development GlobeNewswire November 11, 2025 MGX-001 demonstrated curative FVIII activity in non-human primates Pre-IND regulatory meeting expected in Q4 2025 with investigational new drug (IND) and clinical trial application (CTA) submissions expected in 4Q 2026 EMERYVILLE, Calif., Nov. 11, 2025 (GLOBE

Astec Industries, Inc. (NASDAQ: ASTE) to Participate in Stephens Investment Conference (NASH2025) on November 18, 2025 GlobeNewswire November 11, 2025 CHATTANOOGA, Tenn., Nov. 11, 2025 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ:ASTE) announced today it will participate in the Stephens Investment Conference (NASH2025) on Tuesday, November 18, 2025, in Nashville, Tennessee. Jaco van der Merwe,

Stereotaxis Reports 2025 Third Quarter Financial Results GlobeNewswire November 11, 2025 ST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2025. “We continue to focus on driving commercial progress

— Apollo, Franklin Templeton, KKR and Morgan Stanley are the first clients to join the platform — Permissioned blockchain technology that substantially reduces transaction times and operational friction to support expanded private market access Corastone, the hyperscaler for private market investing, today announced that its platform is now live with Apollo, Morgan Stanley and a

GoNoodle's New Premium Platform, SuperNoodle, Now Available in 67 Public Elementary Schools, Providing Emotional Literacy, Social Connection, and Resilience Resources GoNoodle is providing access to SuperNoodle, its year-long emotional well-being program, to educators of Lancaster County's 67 public elementary schools to support the mental and emotional well-being of elementary students and their families. GoNoodle is